BIOMAT Database Logo BIOMAT Database Logo

MEGX as a test of donor liver function. 1992

G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Queensland Liver Transplant Service, Brisbane, Australia.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
January 2007, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Donor MEGX test fails to predict graft function after orthotopic liver transplant.
January 1997, Transplantation proceedings,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
[Importance of determination of monoethylglycinexylidide (MEGX)--as a liver function test in hepatology and liver transplantation].
January 1999, Bratislavske lekarske listy,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans.
November 1998, Hepatology (Baltimore, Md.),
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Early assessment of transplanted liver function: lignocaine clearance test (MEGX).
July 1997, European journal of anaesthesiology,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
MEGX test in hepatology: the long-sought ultimate quantitative liver function test?
August 1993, Journal of hepatology,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.
April 2000, Surgery,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function.
October 1993, Transplantation proceedings,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
The MEGX test as a measure of liver viability in an isolated liver perfusion circuit.
October 1992, Transplantation proceedings,
G A Balderson, and J M Potter, and P E Hickman, and Y Chen, and S V Lynch, and R W Strong
Which lidocaine dose should be used for the MEGX liver function test?
May 1995, Journal of hepatology,
Copied contents to your clipboard!